Variation in the metagenomic analysis of fecal microbiome composition calls for a standardized operating approach

The reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is the introduction of systemic biases due to differences in methodologies. In our study, we utilized microbial metagenomic data sets from 2,722 f...

Full description

Saved in:
Bibliographic Details
Published inMicrobiology spectrum Vol. 12; no. 12; p. e0151624
Main Authors Xu, Zhilu, Yeoh, Yun Kit, Tun, Hein M., Fei, Na, Zhang, Jingwan, Morrison, Mark, Kamm, Michael A., Yu, Jun, Chan, Francis Ka Leung, Ng, Siew C.
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 30.10.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is the introduction of systemic biases due to differences in methodologies. In our study, we utilized microbial metagenomic data sets from 2,722 fecal samples generated from a single research center to examine the extent to which sample storage and DNA extraction influence the quantification of microbial composition and compared this variable with other sources of technical and biological variation. Our research highlights the impact of DNA extraction methods when analyzing microbiome data and suggests that the microbiome profile may be influenced by differences in the extraction efficiency of bacterial species. With metagenomics sequencing being increasingly used in clinical biology, our findings provide insight into the challenges using metagenomics sequencing in clinical diagnostics, where the detection of certain species and its abundance relative to a “healthy reference” is key.
AbstractList The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine the impact of protocol variations on microbiome composition using metagenomic data sets from a single center. We assessed the variation in a data set consisted of 2,722 subjects, including 9 subcohorts harboring healthy subjects and patients with various disorders, such as inflammatory bowel disease, colorectal cancer, and type 2 diabetes. Two different DNA extraction kits, with or without lyticase, and two sample storage methods were compared. Our results indicated that DNA extraction had the largest impact on gut microbiota diversity among all host factors and sample operating procedures. Healthy subjects matched by age, body mass index, and sample operating methods exhibited reduced, yet significant differences (PERMANOVA, P < 0.05) in gut microbiota composition across studies. The variations contributed by DNA extraction were primarily driven by different recovery efficiency of gram-positive bacteria, e.g., phyla Firmicutes and Actinobacteria. This was further confirmed by a parallel comparison of fecal samples from five healthy subjects and a standard mock community. In addition, the DNA extraction method influenced DNA biomass, quality, and the detection of specific lineage-associated diseases. Sample operating approach and batch effects should be considered for cohorts with large sample size or longitudinal cohorts to ensure that source data were appropriately generated and analyzed. Comparison between samples processed with inconsistent methods should be dealt with caution. This study will promote the establishment of a sample operating standard to enhance our understanding of microbiome and translating in clinical practice.IMPORTANCEThe reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is the introduction of systemic biases due to differences in methodologies. In our study, we utilized microbial metagenomic data sets from 2,722 fecal samples generated from a single research center to examine the extent to which sample storage and DNA extraction influence the quantification of microbial composition and compared this variable with other sources of technical and biological variation. Our research highlights the impact of DNA extraction methods when analyzing microbiome data and suggests that the microbiome profile may be influenced by differences in the extraction efficiency of bacterial species. With metagenomics sequencing being increasingly used in clinical biology, our findings provide insight into the challenges using metagenomics sequencing in clinical diagnostics, where the detection of certain species and its abundance relative to a "healthy reference" is key.The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine the impact of protocol variations on microbiome composition using metagenomic data sets from a single center. We assessed the variation in a data set consisted of 2,722 subjects, including 9 subcohorts harboring healthy subjects and patients with various disorders, such as inflammatory bowel disease, colorectal cancer, and type 2 diabetes. Two different DNA extraction kits, with or without lyticase, and two sample storage methods were compared. Our results indicated that DNA extraction had the largest impact on gut microbiota diversity among all host factors and sample operating procedures. Healthy subjects matched by age, body mass index, and sample operating methods exhibited reduced, yet significant differences (PERMANOVA, P < 0.05) in gut microbiota composition across studies. The variations contributed by DNA extraction were primarily driven by different recovery efficiency of gram-positive bacteria, e.g., phyla Firmicutes and Actinobacteria. This was further confirmed by a parallel comparison of fecal samples from five healthy subjects and a standard mock community. In addition, the DNA extraction method influenced DNA biomass, quality, and the detection of specific lineage-associated diseases. Sample operating approach and batch effects should be considered for cohorts with large sample size or longitudinal cohorts to ensure that source data were appropriately generated and analyzed. Comparison between samples processed with inconsistent methods should be dealt with caution. This study will promote the establishment of a sample operating standard to enhance our understanding of microbiome and translating in clinical practice.IMPORTANCEThe reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is the introduction of systemic biases due to differences in methodologies. In our study, we utilized microbial metagenomic data sets from 2,722 fecal samples generated from a single research center to examine the extent to which sample storage and DNA extraction influence the quantification of microbial composition and compared this variable with other sources of technical and biological variation. Our research highlights the impact of DNA extraction methods when analyzing microbiome data and suggests that the microbiome profile may be influenced by differences in the extraction efficiency of bacterial species. With metagenomics sequencing being increasingly used in clinical biology, our findings provide insight into the challenges using metagenomics sequencing in clinical diagnostics, where the detection of certain species and its abundance relative to a "healthy reference" is key.
ABSTRACT The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine the impact of protocol variations on microbiome composition using metagenomic data sets from a single center. We assessed the variation in a data set consisted of 2,722 subjects, including 9 subcohorts harboring healthy subjects and patients with various disorders, such as inflammatory bowel disease, colorectal cancer, and type 2 diabetes. Two different DNA extraction kits, with or without lyticase, and two sample storage methods were compared. Our results indicated that DNA extraction had the largest impact on gut microbiota diversity among all host factors and sample operating procedures. Healthy subjects matched by age, body mass index, and sample operating methods exhibited reduced, yet significant differences (PERMANOVA, P < 0.05) in gut microbiota composition across studies. The variations contributed by DNA extraction were primarily driven by different recovery efficiency of gram-positive bacteria, e.g., phyla Firmicutes and Actinobacteria. This was further confirmed by a parallel comparison of fecal samples from five healthy subjects and a standard mock community. In addition, the DNA extraction method influenced DNA biomass, quality, and the detection of specific lineage-associated diseases. Sample operating approach and batch effects should be considered for cohorts with large sample size or longitudinal cohorts to ensure that source data were appropriately generated and analyzed. Comparison between samples processed with inconsistent methods should be dealt with caution. This study will promote the establishment of a sample operating standard to enhance our understanding of microbiome and translating in clinical practice.IMPORTANCEThe reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is the introduction of systemic biases due to differences in methodologies. In our study, we utilized microbial metagenomic data sets from 2,722 fecal samples generated from a single research center to examine the extent to which sample storage and DNA extraction influence the quantification of microbial composition and compared this variable with other sources of technical and biological variation. Our research highlights the impact of DNA extraction methods when analyzing microbiome data and suggests that the microbiome profile may be influenced by differences in the extraction efficiency of bacterial species. With metagenomics sequencing being increasingly used in clinical biology, our findings provide insight into the challenges using metagenomics sequencing in clinical diagnostics, where the detection of certain species and its abundance relative to a “healthy reference” is key.
The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine the impact of protocol variations on microbiome composition using metagenomic data sets from a single center. We assessed the variation in a data set consisted of 2,722 subjects, including 9 subcohorts harboring healthy subjects and patients with various disorders, such as inflammatory bowel disease, colorectal cancer, and type 2 diabetes. Two different DNA extraction kits, with or without lyticase, and two sample storage methods were compared. Our results indicated that DNA extraction had the largest impact on gut microbiota diversity among all host factors and sample operating procedures. Healthy subjects matched by age, body mass index, and sample operating methods exhibited reduced, yet significant differences (PERMANOVA, P < 0.05) in gut microbiota composition across studies. The variations contributed by DNA extraction were primarily driven by different recovery efficiency of gram-positive bacteria, e.g., phyla Firmicutes and Actinobacteria. This was further confirmed by a parallel comparison of fecal samples from five healthy subjects and a standard mock community. In addition, the DNA extraction method influenced DNA biomass, quality, and the detection of specific lineage-associated diseases. Sample operating approach and batch effects should be considered for cohorts with large sample size or longitudinal cohorts to ensure that source data were appropriately generated and analyzed. Comparison between samples processed with inconsistent methods should be dealt with caution. This study will promote the establishment of a sample operating standard to enhance our understanding of microbiome and translating in clinical practice.
The reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is the introduction of systemic biases due to differences in methodologies. In our study, we utilized microbial metagenomic data sets from 2,722 fecal samples generated from a single research center to examine the extent to which sample storage and DNA extraction influence the quantification of microbial composition and compared this variable with other sources of technical and biological variation. Our research highlights the impact of DNA extraction methods when analyzing microbiome data and suggests that the microbiome profile may be influenced by differences in the extraction efficiency of bacterial species. With metagenomics sequencing being increasingly used in clinical biology, our findings provide insight into the challenges using metagenomics sequencing in clinical diagnostics, where the detection of certain species and its abundance relative to a “healthy reference” is key.
The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine the impact of protocol variations on microbiome composition using metagenomic data sets from a single center. We assessed the variation in a data set consisted of 2,722 subjects, including 9 subcohorts harboring healthy subjects and patients with various disorders, such as inflammatory bowel disease, colorectal cancer, and type 2 diabetes. Two different DNA extraction kits, with or without lyticase, and two sample storage methods were compared. Our results indicated that DNA extraction had the largest impact on gut microbiota diversity among all host factors and sample operating procedures. Healthy subjects matched by age, body mass index, and sample operating methods exhibited reduced, yet significant differences (PERMANOVA, < 0.05) in gut microbiota composition across studies. The variations contributed by DNA extraction were primarily driven by different recovery efficiency of gram-positive bacteria, e.g., phyla Firmicutes and Actinobacteria. This was further confirmed by a parallel comparison of fecal samples from five healthy subjects and a standard mock community. In addition, the DNA extraction method influenced DNA biomass, quality, and the detection of specific lineage-associated diseases. Sample operating approach and batch effects should be considered for cohorts with large sample size or longitudinal cohorts to ensure that source data were appropriately generated and analyzed. Comparison between samples processed with inconsistent methods should be dealt with caution. This study will promote the establishment of a sample operating standard to enhance our understanding of microbiome and translating in clinical practice.IMPORTANCEThe reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is the introduction of systemic biases due to differences in methodologies. In our study, we utilized microbial metagenomic data sets from 2,722 fecal samples generated from a single research center to examine the extent to which sample storage and DNA extraction influence the quantification of microbial composition and compared this variable with other sources of technical and biological variation. Our research highlights the impact of DNA extraction methods when analyzing microbiome data and suggests that the microbiome profile may be influenced by differences in the extraction efficiency of bacterial species. With metagenomics sequencing being increasingly used in clinical biology, our findings provide insight into the challenges using metagenomics sequencing in clinical diagnostics, where the detection of certain species and its abundance relative to a "healthy reference" is key.
The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine the impact of protocol variations on microbiome composition using metagenomic data sets from a single center. We assessed the variation in a data set consisted of 2,722 subjects, including 9 subcohorts harboring healthy subjects and patients with various disorders, such as inflammatory bowel disease, colorectal cancer, and type 2 diabetes. Two different DNA extraction kits, with or without lyticase, and two sample storage methods were compared. Our results indicated that DNA extraction had the largest impact on gut microbiota diversity among all host factors and sample operating procedures. Healthy subjects matched by age, body mass index, and sample operating methods exhibited reduced, yet significant differences (PERMANOVA, P < 0.05) in gut microbiota composition across studies. The variations contributed by DNA extraction were primarily driven by different recovery efficiency of gram-positive bacteria, e.g., phyla Firmicutes and Actinobacteria. This was further confirmed by a parallel comparison of fecal samples from five healthy subjects and a standard mock community. In addition, the DNA extraction method influenced DNA biomass, quality, and the detection of specific lineage-associated diseases. Sample operating approach and batch effects should be considered for cohorts with large sample size or longitudinal cohorts to ensure that source data were appropriately generated and analyzed. Comparison between samples processed with inconsistent methods should be dealt with caution. This study will promote the establishment of a sample operating standard to enhance our understanding of microbiome and translating in clinical practice.IMPORTANCEThe reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is the introduction of systemic biases due to differences in methodologies. In our study, we utilized microbial metagenomic data sets from 2,722 fecal samples generated from a single research center to examine the extent to which sample storage and DNA extraction influence the quantification of microbial composition and compared this variable with other sources of technical and biological variation. Our research highlights the impact of DNA extraction methods when analyzing microbiome data and suggests that the microbiome profile may be influenced by differences in the extraction efficiency of bacterial species. With metagenomics sequencing being increasingly used in clinical biology, our findings provide insight into the challenges using metagenomics sequencing in clinical diagnostics, where the detection of certain species and its abundance relative to a “healthy reference” is key.
Author Xu, Zhilu
Kamm, Michael A.
Yeoh, Yun Kit
Tun, Hein M.
Fei, Na
Zhang, Jingwan
Ng, Siew C.
Morrison, Mark
Yu, Jun
Chan, Francis Ka Leung
Author_xml – sequence: 1
  givenname: Zhilu
  orcidid: 0000-0002-5552-7534
  surname: Xu
  fullname: Xu, Zhilu
– sequence: 2
  givenname: Yun Kit
  surname: Yeoh
  fullname: Yeoh, Yun Kit
– sequence: 3
  givenname: Hein M.
  surname: Tun
  fullname: Tun, Hein M.
– sequence: 4
  givenname: Na
  surname: Fei
  fullname: Fei, Na
– sequence: 5
  givenname: Jingwan
  surname: Zhang
  fullname: Zhang, Jingwan
– sequence: 6
  givenname: Mark
  surname: Morrison
  fullname: Morrison, Mark
– sequence: 7
  givenname: Michael A.
  surname: Kamm
  fullname: Kamm, Michael A.
– sequence: 8
  givenname: Jun
  surname: Yu
  fullname: Yu, Jun
– sequence: 9
  givenname: Francis Ka Leung
  surname: Chan
  fullname: Chan, Francis Ka Leung
– sequence: 10
  givenname: Siew C.
  orcidid: 0000-0002-6850-4454
  surname: Ng
  fullname: Ng, Siew C.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39475247$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1v1DAQhiNUREvpD-CCfOSSJeOPeHNCqOKjUiUuwNUaO-NdrxI7tbNI7a8n3W2r9sDJ1szrZ8Z63lYnMUWqqvfQrAD4-lOZyM15P64aUNDWXL6qzji0qm5kp0-e3U-ri1J2TdMANIor_qY6FZ3Uikt9Vt38wRxwDimyENm8JTbSjBuKaQyOYcThtoTCkmeeHA5sqeZkQxqJuTROqYTD26U1FOZTZsjKjLHH3Ic76lmaKC_4uGE4TTmh276rXnscCl08nOfV729ff13-qK9_fr-6_HJdo1R6rrtWOFIWCLTnaysbLshqD2gBvLSyp16DE9Y7xQG04N5ZKahrVKd7zaU4r66O3D7hzkw5jJhvTcJgDoWUNwbzHNxAhou1AGo71_VCtkpbuRaq92qNy3iL3cL6fGRNeztS7yjOGYcX0JedGLZmk_4agBY6ofhC-PhAyOlmT2U2YyiOhgEjpX0xAjhvhRL8Pro6RrGM3OzSPi8WioHG3Hs3j97Nwbs5_PTD8-2e1nq0vATgGFjclZLJP0X-D_0H4IO_zA
Cites_doi 10.1136/gutjnl-2019-319635
10.1038/s41598-023-33959-6
10.1136/gutjnl-2020-323020
10.1128/mSystems.00392-19
10.1136/gutjnl-2020-324015
10.1038/s41564-021-01050-3
10.1053/j.gastro.2021.06.056
10.1007/s00248-010-9771-x
10.1158/1078-0432.CCR-16-1599
10.1053/j.gastro.2019.06.048
10.1038/nmeth.3589
10.1128/AEM.02627-17
10.1038/nbt.3981
10.1038/s41591-021-01552-x
10.1038/nbt.3960
10.1136/gutjnl-2019-318532
10.1186/s12866-020-01894-5
10.1111/j.1654-1103.2003.tb02228.x
10.1038/s41564-023-01426-7
10.1186/s40168-021-01059-0
10.1038/s41575-020-0341-5
10.1038/s41598-018-24280-8
10.1371/journal.pone.0202858
10.1038/d41586-018-01023-3
10.1016/s0167-7012(02)00018-0
10.1186/2049-2618-2-19
10.1038/s41591-019-0406-6
10.21105/joss.01686
10.1016/j.chom.2020.08.005
10.1093/bioinformatics/btu170
10.1053/j.gastro.2020.09.056
10.1038/s41582-022-00681-2
ContentType Journal Article
Copyright Copyright © 2024 Xu et al.
Copyright © 2024 Xu et al. 2024 Xu et al.
Copyright_xml – notice: Copyright © 2024 Xu et al.
– notice: Copyright © 2024 Xu et al. 2024 Xu et al.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1128/spectrum.01516-24
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


CrossRef
PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2165-0497
Editor Claesen, Jan
Editor_xml – sequence: 1
  givenname: Jan
  surname: Claesen
  fullname: Claesen, Jan
ExternalDocumentID oai_doaj_org_article_23831e69c9d34657b4835df58a1e1ba9
PMC11619352
spectrum01516-24
39475247
10_1128_spectrum_01516_24
Genre Journal Article
GrantInformation_xml – fundername: InnoHK
  sequence: 0
– fundername: ;
GroupedDBID 53G
AAGFI
AAUOK
AAYXX
ADBBV
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
CITATION
EJD
FF~
FRP
GROUPED_DOAJ
H13
M~E
OK1
RPM
RSF
NPM
UCJ
7X8
5PM
ID FETCH-LOGICAL-a457t-963ce5b1e17f28b4023eb7f1ab11f4b4ded71c3bfc5211732fcb43e90597d7243
IEDL.DBID AAUOK
ISSN 2165-0497
IngestDate Wed Aug 27 01:30:37 EDT 2025
Thu Aug 21 18:29:18 EDT 2025
Fri Jul 11 06:55:55 EDT 2025
Thu Dec 05 18:27:12 EST 2024
Mon Jul 21 05:35:31 EDT 2025
Tue Jul 01 00:43:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords batch effect
DNA extraction
microbiome
metagenomics
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a457t-963ce5b1e17f28b4023eb7f1ab11f4b4ded71c3bfc5211732fcb43e90597d7243
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
F.K.L.C. is a Board Member of CUHK Medical Centre. He is a co-founder, non-executive Board Chairman, and shareholder of GenieBiome Ltd. He receives patent royalties through his affiliated institutions. He has received fees as an advisor and honoraria as a speaker for Eisai Co. Ltd., AstraZeneca, Pfizer Inc., Takeda Pharmaceutical Co., and Takeda (China) Holdings Co. Ltd. S.C.N. has served as an advisory board member for Pfizer, Ferring, Janssen, and Abbvie and received honoraria as a speaker for Ferring, Tillotts, Menarini, Janssen, Abbvie, and Takeda. S.C.N. has received research grants through her affiliated institutions from Olympus, Ferring, and Abbvie. S.C.N. is a scientific co-founder and shareholder of GenieBiome Ltd. S.C.N. receives patent royalties through her affiliated institutions. Z.X., Y.K.Y., H.M.T., J.Z., F.K.L.C., and S.C.N. are named inventors of patent applications held by the CUHK and MagIC that cover the therapeutic and diagnostic use of microbiome.
ORCID 0000-0002-6850-4454
0000-0002-5552-7534
OpenAccessLink https://journals.asm.org/doi/10.1128/spectrum.01516-24
PMID 39475247
PQID 3122635322
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_23831e69c9d34657b4835df58a1e1ba9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11619352
proquest_miscellaneous_3122635322
asm2_journals_10_1128_spectrum_01516_24
pubmed_primary_39475247
crossref_primary_10_1128_spectrum_01516_24
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20241030
PublicationDateYYYYMMDD 2024-10-30
PublicationDate_xml – month: 10
  year: 2024
  text: 20241030
  day: 30
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Microbiology spectrum
PublicationTitleAbbrev Spectrum
PublicationTitleAlternate Microbiol Spectr
PublicationYear 2024
Publisher American Society for Microbiology
Publisher_xml – sequence: 0
  name: American Society for Microbiology
– name: American Society for Microbiology
References e_1_3_5_28_2
e_1_3_5_27_2
e_1_3_5_26_2
e_1_3_5_24_2
e_1_3_5_23_2
e_1_3_5_22_2
e_1_3_5_21_2
e_1_3_5_29_2
e_1_3_5_2_2
e_1_3_5_8_2
e_1_3_5_20_2
e_1_3_5_7_2
e_1_3_5_9_2
e_1_3_5_4_2
e_1_3_5_3_2
e_1_3_5_6_2
e_1_3_5_5_2
e_1_3_5_17_2
e_1_3_5_16_2
e_1_3_5_15_2
e_1_3_5_14_2
e_1_3_5_12_2
e_1_3_5_35_2
e_1_3_5_13_2
e_1_3_5_34_2
e_1_3_5_10_2
e_1_3_5_33_2
e_1_3_5_11_2
e_1_3_5_32_2
e_1_3_5_19_2
e_1_3_5_18_2
McMurdie PJ (e_1_3_5_25_2) 2012; 2012
e_1_3_5_31_2
e_1_3_5_30_2
Lim, MY, Park, Y-S, Kim, J-H, Nam, Y-D (B11) 2020; 20
B23
Dixon, P (B25) 2003; 14
Bolger, AM, Lohse, M, Usadel, B (B19) 2014; 30
Sakowski, E, Uritskiy, G, Cooper, R, Gomes, M, McLaren, MR, Meisel, JS, Mickol, RL, Mintz, CD, Mongodin, EF, Pop, M (B9) 2019; 4
Gupta, A, Osadchiy, V, Mayer, EA (B4) 2020; 17
Wirbel, J, Pyl, PT, Kartal, E, Zych, K, Kashani, A, Milanese, A, Fleck, JS, Voigt, AY, Palleja, A, Ponnudurai, R (B7) 2019; 25
Zuo, T, Sun, Y, Wan, Y, Yeoh, YK, Zhang, F, Cheung, CP, Chen, N, Luo, J, Wang, W, Sung, JJY, Chan, PKS, Wang, K, Chan, FKL, Miao, Y, Ng, SC (B16) 2020; 28
Nearing, JT, Comeau, AM, Langille, MGI (B8) 2021; 9
Liang, Q, Chiu, J, Chen, Y, Huang, Y, Higashimori, A, Fang, J, Brim, H, Ashktorab, H, Ng, SC, Ng, SSM, Zheng, S, Chan, FKL, Sung, JJY, Yu, J (B18) 2017; 23
Munafò, MR, Davey Smith, G (B32) 2018; 553
Ó Cuív, P, Aguirre de Cárcer, D, Jones, M, Klaassens, ES, Worthley, DL, Whitehall, VLJ, Kang, S, McSweeney, CS, Leggett, BA, Morrison, M (B28) 2011; 61
Walker, AW, Hoyles, L (B33) 2023; 8
Costea, PI, Zeller, G, Sunagawa, S, Pelletier, E, Alberti, A, Levenez, F, Tramontano, M, Driessen, M, Hercog, R, Jung, F-E (B6) 2017; 35
McGaughey, KD, Yilmaz-Swenson, T, Elsayed, NM, Cruz, DA, Rodriguez, RR, Kritzer, MD, Peterchev, AV, Gray, M, Lewis, SR, Roach, J, Wetsel, WC, Williamson, DE (B29) 2018; 13
Elie, C, Perret, M, Hage, H, Sentausa, E, Hesketh, A, Louis, K, Fritah-Lafont, A, Leissner, P, Vachon, C, Rostaing, H, Reynier, F, Gervasi, G, Saliou, A (B31) 2023; 13
Tan, AH, Lim, SY, Lang, AE (B3) 2022; 18
Wan, Y, Zuo, T, Xu, Z, Zhang, F, Zhan, H, Chan, D, Leung, T-F, Yeoh, YK, Chan, FKL, Chan, R, Ng, SC (B15) 2022; 71
Mirzayi, C, Renson, A, Zohra, F, Elsafoury, S, Geistlinger, L, Kasselman, LJ, Eckenrode, K, van de Wijgert, J (B34) 2021; 27
Yang, K, Niu, J, Zuo, T, Sun, Y, Xu, Z, Tang, W, Liu, Q, Zhang, J, Ng, EKW, Wong, SKH, Yeoh, YK, Chan, PKS, Chan, FKL, Miao, Y, Ng, SC (B14) 2021; 161
Wesolowska-Andersen, A, Bahl, MI, Carvalho, V, Kristiansen, K, Sicheritz-Pontén, T, Gupta, R, Licht, TR (B30) 2014; 2
Lee, M, Chang, EB (B2) 2021; 160
Pollock, J, Glendinning, L, Wisedchanwet, T, Watson, M (B26) 2018; 84
Mills, RH, Dulai, PS, Vázquez-Baeza, Y, Sauceda, C, Daniel, N, Gerner, RR, Batachari, LE, Malfavon, M, Zhu, Q, Weldon, K, Humphrey, G, Carrillo-Terrazas, M, Goldasich, LD, Bryant, M, Raffatellu, M, Quinn, RA, Gewirtz, AT, Chassaing, B, Chu, H, Sandborn, WJ, Dorrestein, PC, Knight, R, Gonzalez, DJ (B5) 2022; 7
Yeoh, YK, Zuo, T, Lui, G-Y, Zhang, F, Liu, Q, Li, AY, Chung, AC, Cheung, CP, Tso, EY, Fung, KS, Chan, V, Ling, L, Joynt, G, Hui, D-C, Chow, KM, Ng, SSS, Li, T-M, Ng, RW, Yip, TC, Wong, G-H, Chan, FK, Wong, CK, Chan, PK, Ng, SC (B17) 2021; 70
Song, M, Chan, AT, Sun, J (B1) 2020; 158
McOrist, AL, Jackson, M, Bird, AR (B10) 2002; 50
Yeoh, YK, Chen, Z, Wong, MCS, Hui, M, Yu, J, Ng, SC, Sung, JJY, Chan, FKL, Chan, PKS (B13) 2020; 69
McMurdie, PJ, Holmes, S (B24) 2012; 2012
Sinha, R, Abu-Ali, G, Vogtmann, E, Fodor, AA, Ren, B, Amir, A, Schwager, E, Crabtree, J, Ma, S, Abnet, CC, Knight, R, White, O, Huttenhower, C (B27) 2017; 35
Liang, JQ, Li, T, Nakatsu, G, Chen, Y-X, Yau, TO, Chu, E, Wong, S, Szeto, CH, Ng, SC, Chan, FKL, Fang, J-Y, Sung, JJY, Yu, J (B12) 2020; 69
Zaheer, R, Noyes, N, Ortega Polo, R, Cook, SR, Marinier, E, Van Domselaar, G, Belk, KE, Morley, PS, McAllister, TA (B20) 2018; 8
Truong, DT, Franzosa, EA, Tickle, TL, Scholz, M, Weingart, G, Pasolli, E, Tett, A, Huttenhower, C, Segata, N (B21) 2015; 12
Wickham, H, Averick, M, Bryan, J, Chang, W, McGowan, L, François, R, Grolemund, G, Hayes, A, Henry, L, Hester, J, Kuhn, M, Pedersen, T, Miller, E, Bache, S, Müller, K, Ooms, J, Robinson, D, Seidel, D, Spinu, V, Takahashi, K, Vaughan, D, Wilke, C, Woo, K, Yutani, H (B22) 2019; 4
References_xml – ident: e_1_3_5_14_2
  doi: 10.1136/gutjnl-2019-319635
– ident: e_1_3_5_32_2
  doi: 10.1038/s41598-023-33959-6
– ident: e_1_3_5_18_2
  doi: 10.1136/gutjnl-2020-323020
– ident: e_1_3_5_10_2
  doi: 10.1128/mSystems.00392-19
– ident: e_1_3_5_16_2
  doi: 10.1136/gutjnl-2020-324015
– ident: e_1_3_5_6_2
  doi: 10.1038/s41564-021-01050-3
– ident: e_1_3_5_15_2
  doi: 10.1053/j.gastro.2021.06.056
– ident: e_1_3_5_29_2
  doi: 10.1007/s00248-010-9771-x
– ident: e_1_3_5_19_2
  doi: 10.1158/1078-0432.CCR-16-1599
– ident: e_1_3_5_2_2
  doi: 10.1053/j.gastro.2019.06.048
– ident: e_1_3_5_22_2
  doi: 10.1038/nmeth.3589
– ident: e_1_3_5_27_2
  doi: 10.1128/AEM.02627-17
– volume: 2012
  start-page: 235
  year: 2012
  ident: e_1_3_5_25_2
  article-title: Phyloseq: a bioconductor package for handling and analysis of high-throughput phylogenetic sequence data
  publication-title: Pac Symp Biocomput
– ident: e_1_3_5_28_2
  doi: 10.1038/nbt.3981
– ident: e_1_3_5_35_2
  doi: 10.1038/s41591-021-01552-x
– ident: e_1_3_5_7_2
  doi: 10.1038/nbt.3960
– ident: e_1_3_5_13_2
  doi: 10.1136/gutjnl-2019-318532
– ident: e_1_3_5_12_2
  doi: 10.1186/s12866-020-01894-5
– ident: e_1_3_5_24_2
– ident: e_1_3_5_26_2
  doi: 10.1111/j.1654-1103.2003.tb02228.x
– ident: e_1_3_5_34_2
  doi: 10.1038/s41564-023-01426-7
– ident: e_1_3_5_9_2
  doi: 10.1186/s40168-021-01059-0
– ident: e_1_3_5_5_2
  doi: 10.1038/s41575-020-0341-5
– ident: e_1_3_5_21_2
  doi: 10.1038/s41598-018-24280-8
– ident: e_1_3_5_30_2
  doi: 10.1371/journal.pone.0202858
– ident: e_1_3_5_33_2
  doi: 10.1038/d41586-018-01023-3
– ident: e_1_3_5_11_2
  doi: 10.1016/s0167-7012(02)00018-0
– ident: e_1_3_5_31_2
  doi: 10.1186/2049-2618-2-19
– ident: e_1_3_5_8_2
  doi: 10.1038/s41591-019-0406-6
– ident: e_1_3_5_23_2
  doi: 10.21105/joss.01686
– ident: e_1_3_5_17_2
  doi: 10.1016/j.chom.2020.08.005
– ident: e_1_3_5_20_2
  doi: 10.1093/bioinformatics/btu170
– ident: e_1_3_5_3_2
  doi: 10.1053/j.gastro.2020.09.056
– ident: e_1_3_5_4_2
  doi: 10.1038/s41582-022-00681-2
– volume: 35
  start-page: 1077
  year: 2017
  end-page: 1086
  ident: B27
  article-title: Assessment of variation in microbial community amplicon sequencing by the microbiome quality control (MBQC) project consortium
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.3981
– volume: 69
  start-page: 1998
  year: 2020
  end-page: 2007
  ident: B13
  article-title: Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-319635
– volume: 161
  start-page: 1257
  year: 2021
  end-page: 1269
  ident: B14
  article-title: Alterations in the gut virome in obesity and type 2 diabetes mellitus
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2021.06.056
– ident: B23
  article-title: ggpubr WH . ggpubr: ‘ggplot2’ based publication ready plots
– volume: 25
  start-page: 679
  year: 2019
  end-page: 689
  ident: B7
  article-title: Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0406-6
– volume: 20
  year: 2020
  ident: B11
  article-title: Evaluation of fecal DNA extraction protocols for human gut microbiome studies
  publication-title: BMC Microbiol
  doi: 10.1186/s12866-020-01894-5
– volume: 50
  start-page: 131
  year: 2002
  end-page: 139
  ident: B10
  article-title: A comparison of five methods for extraction of bacterial DNA from human faecal samples
  publication-title: J Microbiol Methods
  doi: 10.1016/s0167-7012(02)00018-0
– volume: 2012
  start-page: 235
  year: 2012
  end-page: 246
  ident: B24
  article-title: Phyloseq: a bioconductor package for handling and analysis of high-throughput phylogenetic sequence data
  publication-title: Pac Symp Biocomput
– volume: 61
  start-page: 353
  year: 2011
  end-page: 362
  ident: B28
  article-title: The effects from DNA extraction methods on the evaluation of microbial diversity associated with human colonic tissue
  publication-title: Microb Ecol
  doi: 10.1007/s00248-010-9771-x
– volume: 28
  start-page: 741
  year: 2020
  end-page: 751
  ident: B16
  article-title: Human-gut-DNA virome variations across geography, ethnicity, and urbanization
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.08.005
– volume: 13
  year: 2018
  ident: B29
  article-title: Comparative evaluation of a new magnetic bead-based DNA extraction method from fecal samples for downstream next-generation 16S rRNA gene sequencing
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0202858
– volume: 84
  year: 2018
  ident: B26
  article-title: The madness of microbiome: attempting to find consensus "Best Practice" for 16S microbiome studies
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.02627-17
– volume: 7
  start-page: 262
  year: 2022
  end-page: 276
  ident: B5
  article-title: Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity
  publication-title: Nat Microbiol
  doi: 10.1038/s41564-021-01050-3
– volume: 160
  start-page: 524
  year: 2021
  end-page: 537
  ident: B2
  article-title: Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.09.056
– volume: 23
  start-page: 2061
  year: 2017
  end-page: 2070
  ident: B18
  article-title: Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-16-1599
– volume: 158
  start-page: 322
  year: 2020
  end-page: 340
  ident: B1
  article-title: Influence of the gut microbiome, diet, and environment on risk of colorectal cancer
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.06.048
– volume: 70
  start-page: 698
  year: 2021
  end-page: 706
  ident: B17
  article-title: Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-323020
– volume: 14
  start-page: 927
  year: 2003
  end-page: 930
  ident: B25
  article-title: VEGAN, a package of R functions for community ecology
  publication-title: J Veg Sci
  doi: 10.1111/j.1654-1103.2003.tb02228.x
– volume: 35
  start-page: 1069
  year: 2017
  end-page: 1076
  ident: B6
  article-title: Towards standards for human fecal sample processing in metagenomic studies
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.3960
– volume: 27
  start-page: 1885
  year: 2021
  end-page: 1892
  ident: B34
  article-title: Reporting guidelines for human microbiome research: the STORMS checklist
  publication-title: Nat Med
  doi: 10.1038/s41591-021-01552-x
– volume: 17
  start-page: 655
  year: 2020
  end-page: 672
  ident: B4
  article-title: Brain-gut-microbiome interactions in obesity and food addiction
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-020-0341-5
– volume: 9
  year: 2021
  ident: B8
  article-title: Identifying biases and their potential solutions in human microbiome studies
  publication-title: Microbiome
  doi: 10.1186/s40168-021-01059-0
– volume: 18
  start-page: 476
  year: 2022
  end-page: 495
  ident: B3
  article-title: The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic
  publication-title: Nat Rev Neurol
  doi: 10.1038/s41582-022-00681-2
– volume: 12
  start-page: 902
  year: 2015
  end-page: 903
  ident: B21
  article-title: MetaPhlAn2 for enhanced metagenomic taxonomic profiling
  publication-title: Nat Methods
  doi: 10.1038/nmeth.3589
– volume: 30
  start-page: 2114
  year: 2014
  end-page: 2120
  ident: B19
  article-title: Trimmomatic: a flexible trimmer for Illumina sequence data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu170
– volume: 8
  start-page: 1392
  year: 2023
  end-page: 1396
  ident: B33
  article-title: Human microbiome myths and misconceptions
  publication-title: Nat Microbiol
  doi: 10.1038/s41564-023-01426-7
– volume: 71
  start-page: 910
  year: 2022
  end-page: 918
  ident: B15
  article-title: Underdevelopment of the gut microbiota and bacteria species as non-invasive markers of prediction in children with autism spectrum disorder
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-324015
– volume: 4
  start-page: 1686
  year: 2019
  ident: B22
  article-title: Welcome to the tidyverse
  publication-title: JOSS
  doi: 10.21105/joss.01686
– volume: 69
  start-page: 1248
  year: 2020
  end-page: 1257
  ident: B12
  article-title: A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-318532
– volume: 8
  year: 2018
  ident: B20
  article-title: Impact of sequencing depth on the characterization of the microbiome and resistome
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-24280-8
– volume: 553
  start-page: 399
  year: 2018
  end-page: 401
  ident: B32
  article-title: Robust research needs many lines of evidence
  publication-title: Nature New Biol
  doi: 10.1038/d41586-018-01023-3
– volume: 13
  year: 2023
  ident: B31
  article-title: Comparison of DNA extraction methods for 16S rRNA gene sequencing in the analysis of the human gut microbiome
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-33959-6
– volume: 4
  year: 2019
  ident: B9
  article-title: Current state of and future opportunities for prediction in microbiome research: report from the mid-Atlantic microbiome meet-up in Baltimore on 9 January 2019
  publication-title: mSystems
  doi: 10.1128/mSystems.00392-19
– volume: 2
  start-page: 19
  year: 2014
  ident: B30
  article-title: Choice of bacterial DNA extraction method from fecal material influences community structure as evaluated by metagenomic analysis
  publication-title: Microbiome
  doi: 10.1186/2049-2618-2-19
SSID ssj0001105252
Score 2.3245718
Snippet The reproducibility of human gut microbiome studies has been suboptimal across cohorts and study design choices. One possible reason for the disagreement is...
The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine the impact...
ABSTRACT The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine...
SourceID doaj
pubmedcentral
proquest
asm2
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0151624
SubjectTerms batch effect
DNA extraction
Human Microbiome
metagenomics
microbiome
Research Article
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA-yIPQirVY7WiUFQRDGbpKXycyxiqUI9eRKbyGfdKAz27rbg_71fcnMLLsievE6CUx4H3m_l-T9HiFvawjAHIul4I3FBMU0ZS3reakQ70vHuDdVqne-_FpdLODLlbzaavWV3oQN9MCD4E4xpAgWqsY1XkAllQXEDD7K2rDArMmlexjztpKpfLrCUn82Pl5j4h58mgsXf9x3HzD-sapMFe4zs-r4TjzKtP1_wpq_P5ncikHn--TJCB7p2bDoA_Io9E_J46Gd5M9n5O47Jr5Z0rTtKSI72oW1SSysXeuoGelH6DLSGFA1tGsHFqYu0PSyfHy-RXHoZkURzFJDp5OG9lfwdHmbGJgx1tGJifyQLM4_f_t0UY4tFUoDUq1LdDcXpEXRqchri8mjCFZFZixjESz44BVzwkaHYZ0pwaOzIEKDIEx5xUE8J7N-2YcjQsFEz90c0yHhwSPukE7gbgUAEjNdVxXkXZKvHn1ipXO6wWs9aUJnTWgOBXk_qUDfDhwbf5v8MSlpMzHRY-cPaDR6NBr9L6MpyMmkYo3ulO5ITB-W9ystGE_0PLjNFeTFoPLNr0QDSnJQBal3jGFnLbsjfXudKbsZAusGse7L_7H6V2SPI7TKEXR-TGYon_AaodHavsle8AC0Kg0f
  priority: 102
  providerName: Directory of Open Access Journals
Title Variation in the metagenomic analysis of fecal microbiome composition calls for a standardized operating approach
URI https://www.ncbi.nlm.nih.gov/pubmed/39475247
https://journals.asm.org/doi/10.1128/spectrum.01516-24
https://www.proquest.com/docview/3122635322
https://pubmed.ncbi.nlm.nih.gov/PMC11619352
https://doaj.org/article/23831e69c9d34657b4835df58a1e1ba9
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKKyQuiPJMgcpISEhIKWt7HCfHBbWqQMCFRb1ZfopITbaw20P59YydZGFRVfUaO3Iyn8fzjR-fCXldQwDmWCwFbywmKKYpa1nPSoV8XzrGvanSeefPX6rTBXw8k2c7pJrOwowWXB2ZVZcX8jeezet3-fDhr8vuCGMYq0oOd8ie5A2gQ-7N54uvn_7OrrB0PxsflzGvfRfHYGyDb8WjLNt_Hdf8f8vkPzHo5AG5P5JHOh_Q3ic7oX9I7g7XSV49Ij-_Y-KbLU3bniKzo11Ym6TC2rWOmlF-hC4jjQGhoV07qDB1gaad5eP2LYpF5yuKZJYaOs00tL-Dp8uLpMCMsY5OSuSPyeLk-NuH03K8UqE0INW6RHdzQVoWmIq8tpg8imBVZMYyFsGCD14xJ2x0GNaZEjw6CyI0SMKUVxzEE7LbL_vwjFAw0XM3w3RIePDIO6QTOFoBgMRM11UFeZPsqydEdU43eK0nJHRGQnMoyNsJAn0xaGzcVPl9AmlTMclj5wfYWfTobRp5iGChalzjBVRSWUCi6aOsDf65NU1BXk0Qa3SntEZi-rC8XGnBeJLnwWGuIE8HyDdNiQaU5KAKUm91hq1v2S7p2x9ZspshsW6Q6x7c2ijPyT2O_CmHydkLsouF4SXyn7U9HDv7YZ4_-AN14QYh
linkProvider American Society for Microbiology
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagFYIL4k14GgkJCSll_YqT44KoFvrg0kW9WX6KoCbbNtsD_HrGjlNYVCGusSMnHo_nG8_4G4Re19xzYkkoGW0MOCi6KWtRz0oJeF9YQp2u4n3ng8NqseSfj8VxzqqMd2G-x7q8J8OOHroUx4-KHQ-icz3C-l26gHh-0e2AHSNVSfl1tB1jh-B4bc_nyy97v09YSKzRRnMo88p3YR-GgeiGTUrU_Vfhzb_TJv-wQ7t30O0MIPF8lPhddM3399CNsaTkj_vo7Cs4v2m2cdtjQHe482sdmVi71mKdKUjwKuDgQTy4a0cmps7jmF2eU7gwNJ0MGAAt1ng6bWh_eodXp5GFGewdntjIH6Dl7sejD4syl1UoNRdyXYLKWS8M8UQGWhtwIJk3MhBtCAnccOedJJaZYMG0E8losIYz3wAQk05Szh6irX7V-8cIcx0ctTNwiZjjDrCHsAx2LM65AG_XVgV6E-dXZb0YVHI5aK0mSagkCUV5gd5OIlCnI8_Gvzq_j0K67BgpstMDWDEqa5wCLMKIrxrbOMYrIQ0HsOmCqDX8udFNgV5NIlagUjFOonu_uhgUIzRS9MBWV6BHo8gvh2INl4JyWaB6YzFsfMtmS99-S7TdBMB1A3j3yX9Pykt0c3F0sK_2Px3uPUW3KOCpZDZnz9AWdPTPAQ-tzYu88H8BrKQJjw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jb9QwFLZgKhCXip2wGgkJCSnteIuT47QwKhQKBwb1ZnkVkUhmYKaH8ut5dpzCoApxjR05eZ-f3_e8fEboRc09J5aEktHGQIKim7IW9bSUwPeFJdTpKp53_nBSHS34u1NxmndVxrMw2YLrPb3u0kJ-9OyVC_k-wno_HUD8cdbtQRwjVUn5VbSTFqsmaGc2W3w8_j3DQuIdbTQvZV76LozD0A7diklJuv8yvvn3tsk_4tD8JtrNBBLPBsRvoSu-v42uDVdKnt9B379A8pusjdseA7vDnd_oqMTatRbrLEGClwEHD_Dgrh2UmDqP4-7yvIULQ9G3NQZCizUeZxvan97h5SqqMEO8w6Ma-V20mL_5fHhU5msVSs2F3JTgctYLQzyRgdYGEkjmjQxEG0ICN9x5J4llJlgI7UQyGqzhzDdAxKSTlLN7aNIve_8AYa6Do3YKKRFz3AH3EJbBiMU5F5Dt2qpAL6N91YiqSikHrdWIhEpIKMoL9GqEQK0GnY1_VT6IIF1UjBLZ6QF0GJU9TgEXYcRXjW0c45WQhgPZdEHUGv7c6KZAz0eIFbhUXCfRvV-erRUjNEr0wFBXoPsD5BdNsYZLQbksUL3VGba-Zbukb78m2W4C5LoBvvvwv43yDF3_9Hqu3r89OX6EblCgUylqTh-jCdTzT4AObczT3O9_AYaaCSs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Variation+in+the+metagenomic+analysis+of+fecal+microbiome+composition+calls+for+a+standardized+operating+approach&rft.jtitle=Microbiology+spectrum&rft.au=Xu%2C+Zhilu&rft.au=Yeoh%2C+Yun+Kit&rft.au=Tun%2C+Hein+M.&rft.au=Fei%2C+Na&rft.date=2024-10-30&rft.pub=American+Society+for+Microbiology&rft.eissn=2165-0497&rft.volume=12&rft.issue=12&rft_id=info:doi/10.1128%2Fspectrum.01516-24&rft.externalDocID=spectrum01516-24
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2165-0497&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2165-0497&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2165-0497&client=summon